Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Debt / NOTE 1.000% 9/1
-
Unit price / market price
-
$0.9275
-
Total 13F principal
-
$976,407,604
-
Principal change
-
+$976,407,604
-
Total reported value
-
$910,151,140
-
Number of holders
-
55
-
Value change
-
+$910,150,772
-
Number of buys
-
55
Institutional Holders of ALNYLAM PHARMACEUTICALS INC - NOTE 1.000% 9/1 as of Q3 2023
As of 30 Sep 2023 ALNYLAM PHARMACEUTICALS INC - NOTE 1.000% 9/1 had 55 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $976,407,604 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Voya Investment Management LLC, Linden Advisors LP, UBS ASSET MANAGEMENT AMERICAS INC, Calamos Advisors LLC, STEELHEAD PARTNERS LLC, Invesco Ltd., ADVENT CAPITAL MANAGEMENT /DE/, CITADEL ADVISORS LLC, READYSTATE ASSET MANAGEMENT LP, and Polar Asset Management Partners Inc..
This table shows 55 bond principal holders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.